Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
Ryan D. Cassaday, MD
Daniel J. DeAngelo, MD, PhD
Beyond the Joint: Cross-Specialty Solutions for Advancing TGCT Patient Care
A.J. Gelderblom, MD, PhD
Michiel van de Sande, MD, PhD
Chelsea Cole, MD
The Tumor That’s Not So Tiny: Understanding the Impact of TGCT
Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
Clinical Evidence in Focus: Interpreting Data on Systemic Therapy Targeting CSF1R
Emerging Evidence in Focus: Interpreting Data on Next-Generation CSF1R TKIs
Applying the Evidence: TGCT Treatment Insights for Sports Medicine Physicians
From Data to Debate: Global Perspectives on HR+/HER2- mBC Care
Komal Jhaveri, MD, FACP
Giuseppe Curigliano, MD, PhD
Cynthia Villarreal-Garza, MD, DSc
Hiraji Iwata, MD, PhD
Routes Reconsidered: A Case-Based Debate in SERD Selection
Safety of CDK4/6 Inhibitors: Anticipation, Prevention, and Management of Adverse Events
Spotlight on Europe: Adapting the Evidence
Safety and Tolerability of CDH6-Directed Antibody-Drug Conjugates
Kathleen Moore, MD, MS
MOA: CDH6-Targeted Antibody-Drug Conjugates
Looking Ahead: Integrating CDH6-Targeted Therapies Into Ovarian Cancer Treatment Paradigms
Joyce F. Liu, MD, MPH
Clinical Evidence: Insights From Early Trials of CDH6-Targeted Therapies
Partnering with Patients: Improving First-Line Treatment Selection in Upper GI Cancers Through Shared Decision-Making
James M. Cleary, MD, PhD
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.